PSS4 Evidence-Based Budgetary Impact Analysis of Ustekinumab in a Health Plan with Moderate-to-Severe Plaque Psoriasis Patients 2
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.1348
https://www.valueinhealthjournal.com/article/S1098-3015(12)01413-1/fulltext
Section Title :
Sensory Systems Disorders
Section Order :
884
First Page :
A250
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01413-1&doi=10.1016/j.jval.2012.03.1348